An Acceptability Study to Evaluate the Compliance, Gastrointestinal Tolerance, Palatability and Metabolic Control of Children With Phenylketonuria (PKU) When Using PKU UP (a Food for Special Medical Purposes) as Part of Dietary Management.

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

PKU UP is a prospective, single-arm, open-label, 26-week acceptability study to evaluate PKU UP for the dietary management of participants with phenylketonuria (PKU). Up to 15 participants aged 1 - 10 years old will be recruited and it is anticipated the study will open in at least three sites in the United Kingdom (UK) to recruit the target number of participants in the required timeframe.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 10
Healthy Volunteers: f
View:

• Diagnosis of PKU requiring a low-protein diet and protein substitute.

• Participants who are adherent with their blood phenylalanine (Phe) testing, in the opinion of the investigator.

• Participants aged 1-10 years.

• Participants who in the opinion of the investigator are anticipated to be able to take at least half of their daily protein equivalent requirement from PKU UP (in order to assess this, a taste test (or similar) may be conducted at investigator's discretion as part of the screening process).

• Willingly given, written, informed consent from the parent(s)/guardian(s).

• Willingly given, written assent by the participant (if appropriate).

Locations
Other Locations
United Kingdom
Royal Belfast Hospital for Sick Children
RECRUITING
Belfast
Birmingham Children's Hospital
RECRUITING
Birmingham
St. Luke's Hospital
RECRUITING
Bradford
University Hospitals Bristol and Weston NHS Foundation Trust
RECRUITING
Bristol
Great Ormond Street Hospital for Children NHS Foundation Trust
RECRUITING
London
Nottingham Children's Hospital
RECRUITING
Nottingham
Sheffield Children's Hospital
RECRUITING
Sheffield
Contact Information
Primary
Clinical Trials
ClinicalTrialsTeam@Vitaflo.co.uk
0151 709 9020
Time Frame
Start Date: 2024-01-11
Estimated Completion Date: 2026-05-31
Participants
Target number of participants: 15
Treatments
Experimental: PKU UP
All participants will be assessed by their dietitian and prescribed an appropriate amount of the study product, PKU UP, to manage their phenylketonuria.
Related Therapeutic Areas
Sponsors
Leads: Vitaflo International, Ltd
Collaborators: Birmingham Women's and Children's NHS Foundation Trust

This content was sourced from clinicaltrials.gov